These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38481653)

  • 21. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
    Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
    Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Drug Resistance Pattern of
    Mohammed KAS; Khudhair GS; Al-Rabeai DB
    Pol J Microbiol; 2022 May; 71(2):205-215. PubMed ID: 35675816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study.
    Li M; Zhang Y; Wu Z; Jiang Y; Sun R; Yang J; Li J; Lin H; Zhang R; Jiang Q; Wang L; Wu X; Yu F; Yuan J; Yang C; Shen X
    Emerg Microbes Infect; 2024 Dec; 13(1):2302837. PubMed ID: 38205528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study.
    Hu Y; Hoffner S; Jiang W; Wang W; Xu B
    BMC Infect Dis; 2010 Feb; 10():43. PubMed ID: 20187977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    Moga S; Bobosha K; Fikadu D; Zerihun B; Diriba G; Amare M; Kempker RR; Blumberg HM; Abebe T
    PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors.
    Shen X; DeRiemer K; Yuan ZA; Shen M; Xia Z; Gui X; Wang L; Gao Q; Mei J
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):253-9. PubMed ID: 19146756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia.
    Claassens M; Dreyer V; Nepolo E; Mokomele Q; van Rooyen G; Ruswa N; Günther G; Niemann S
    Microbiol Spectr; 2022 Oct; 10(5):e0158622. PubMed ID: 36165641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.
    Oostvogels S; Ley SD; Heupink TH; Dippenaar A; Streicher EM; De Vos E; Meehan CJ; Dheda K; Warren R; Van Rie A
    Microb Genom; 2022 Apr; 8(4):. PubMed ID: 35471145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
    Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
    Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
    Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
    Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
    Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
    Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission pattern of drug-resistant tuberculosis and its implication for tuberculosis control in eastern rural China.
    Hu Y; Mathema B; Jiang W; Kreiswirth B; Wang W; Xu B
    PLoS One; 2011 May; 6(5):e19548. PubMed ID: 21589863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of multidrug-resistant tuberculosis in Shimen community in Shanghai, China: a molecular epidemiology study.
    Han Z; Li J; Sun G; Gu K; Zhang Y; Yao H; Jiang Y
    BMC Infect Dis; 2021 Oct; 21(1):1118. PubMed ID: 34715793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis.
    Zhang L; Han X; Ge Q; Shu W; Sun Y; Gao J; Xie S; Wang J; Gao W
    BMC Infect Dis; 2024 Jan; 24(1):7. PubMed ID: 38166793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012-2020 Period Analysis.
    Lecai J; Mijiti P; Chuangyue H; Mingzhen L; Qian G; Weiguo T; Jihong C
    Infect Drug Resist; 2021; 14():4481-4491. PubMed ID: 34737588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century.
    Ngabonziza JCS; Rigouts L; Torrea G; Decroo T; Kamanzi E; Lempens P; Rucogoza A; Habimana YM; Laenen L; Niyigena BE; Uwizeye C; Ushizimpumu B; Mulders W; Ivan E; Tzfadia O; Muvunyi CM; Migambi P; Andre E; Mazarati JB; Affolabi D; Umubyeyi AN; Nsanzimana S; Portaels F; Gasana M; de Jong BC; Meehan CJ
    J Clin Tuberc Other Mycobact Dis; 2022 May; 27():100299. PubMed ID: 35146133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.